C3 (Complement Component 3) Glomerulopathy
Nephrology·MeSH: Complement Component 3 Deficiency, Autosomal Recessive
Prevalence
0.5 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target C3 (Complement Component 3) Glomerulopathy?
There are 1 clinical trial targeting C3 (Complement Component 3) Glomerulopathy tracked by BioSniper.
What is the prevalence of C3 (Complement Component 3) Glomerulopathy?
The estimated prevalence of C3 (Complement Component 3) Glomerulopathy is approximately 0.5 per 100,000 population.
Deep-dive into C3 (Complement Component 3) Glomerulopathy
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis